Figure 6
TACE combined with oxygen enhancement therapy. 51% of short-term complete responders fail therapy 90 days-post TACE administration. Combining TACE with HBO can radically improve treatment outcomes, with only 29% of short-term complete responders predicted to fail therapy 90 days-post TACE + oxygen enhancement administration. Of the patients who fail treatment within 90 days-post TACE administration, 62% become long-term complete responders if treated with TACE + oxygen enhancement. However, this combination can induce tumour relapse in a small subset of patients who were long-term complete responders when treated with TACE alone.
